SPOTLIGHT -
Feature
Article
Author(s):
Learn more about best practices when treating comorbid trauma and psychosis.
Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.
Primary Endpoint of Phase 3 Trial Met: BXCL501 for Agitation Associated With Bipolar Disorders or Schizophrenia
Treating ‘Morally Objectionable’ Patients
Database Lock in Trial for New At-Home Treatment of Agitation in Bipolar Disorders and Schizophrenia
Teamwork and Trauma: a Conversation With Kasey Grewe, MD, and Niesha Voigt, MD
How Our Past Trauma Drives Our Brain’s Response to New Stress
Risk Factors for Catatonia Relapse in Psychotic and Affective Disorders